CD209 and infection: Since the chronic and end-stage R5 isolates that we studied displayed diverse replicative capacity in PBMC [12], we took care to study the relative efficacy of DC-SIGN utilization by setting up parallel direct target cell infections and DC-SIGN mediated infections.